
Bradiswift 5mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Ivabradine (5mg)
Overview Bradiswift 5mg Tablet
CardioSwift 5mg tablets treat angina pectoris (chest pain stemming from heart issues) and chronic congestive heart failure. It optimizes cardiac function by reducing heart rate, thereby alleviating chest pain and minimizing hospitalizations for heart failure patients. Dosage varies depending on the condition being treated. As treatment for angina or heart failure is generally lifelong, discontinuation requires physician consultation. Administer with food at the same time daily. Overdosage can cause bradycardia, fatigue, and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic abnormalities. Serious adverse effects like syncope and significant cardiac rhythm changes necessitate emergency medical care. Refrain from driving until the medication's effects are known. CardioSwift 5mg tablets are contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, hypotension, or recently exacerbated heart failure. This medication interacts with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Uses of Bradiswift 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Bradiswift 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 5mg Bradiswift tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
Common Side effects of Bradiswift 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Bradiswift 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the 5mg Bradiswift tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Bradiswift 5mg Tablet works:
CardioSlow 5mg tablets decrease heart rate, thereby diminishing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Bradiswift 5mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Using Bradiswift 5mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in animals and pregnant humans reveals considerable harm to the fetus.
Breast feedingUNSAFE
Lactation and the use of Bradiswift 5mg tablets are incompatible due to the potential for infant harm. Evidence indicates the medication poses a risk of toxicity to the nursing infant.
DrivingUNSAFE
Taking a Bradiswift 5mg tablet might impair your driving ability. This medication can produce temporary visual disturbances, primarily light flashes (phosphenes). Night driving should be considered with caution due to this potential effect.
KidneyCAUTION
Exercise caution when administering Bradiswift 5mg Tablets to individuals with severely impaired kidney function. Dosage modifications for Bradiswift 5mg Tablets may be necessary. Physician consultation is recommended. Data regarding Bradiswift 5mg Tablet use in patients with severe kidney disease is limited.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Bradiswift 5mg tablets, as dose modification may be necessary. Consult your physician for guidance. Bradiswift 5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Bradiswift 5mg Tablet :
Omit any missed Bradiswift 5mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Bradiswift 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Sodium channel blockers targeting the sinoatrial node's If current |
